ALPI and metabolic syndrome: The role of IAP in maintaining intestinal homeostasis was discovered by the observation that its expression was markedly decreased in many gastrointestinal and metabolic disorders such as inflammatory bowel disease (IBD) [17] necrotizing enterocolitis [18], and metabolic syndrome [19].